跳至主要内容
临床试验/JPRN-UMIN000015330
JPRN-UMIN000015330招募中2 期

A phase II trial of neoadjuvant chemotherapy using the combination of gemcitabine and cisplatin for patients with initially unresectable locally advanced biliary tract cancer. - A phase II trial of neoadjuvant chemotherapy using the combination of gemcitabine and cisplatin for patients with initially unresectable locally advanced biliary tract cancer.

Adjuvant therapy for BTC Research Group0 个研究点目标入组 50 人开始时间: 2014年10月3日最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
发起方
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1. Pulmonary fibrosis or interstitial pneumonia 2. Severe myelosuppression 3. Pregnant female, possibly pregnant females, females wishing to become pregnant, and females feeding babies. 4. Serious renal dysfunction 5. Serious liver dysfunction 6. Patients with severe allergy 7. History of breast or lung radiation 8. Active infection 9. Patient with uncontrollable pleural effusion and/or severe edema 10. Active double cancer 11. Severe complications including uncontrollable diabetes mellitus. 12. Severe mental disorder 13. Inadequate physical condition, as diagnosed by primary physician

研究者

发起方
Adjuvant therapy for BTC Research Group

相似试验